Related Experiment Videos

Birth prevalence of homocystinuria

Helga Refsum1, Ase Fredriksen, Klaus Meyer

  • 1Department of Pharmacology, University of Oxford, United Kingdom. helga.refsum@pharmacology.oxford.ac.uk

The Journal of Pediatrics
|June 12, 2004
PubMed

Insights

Early detection of homocystinuria, a condition caused by cystathionine beta-synthase deficiency, can prevent severe complications. This study screened 1133 newborns, finding a higher prevalence than previously thought.

Area of Science:

  • Medical Genetics
  • Biochemistry
  • Newborn Screening

Background:

  • Homocystinuria, caused by cystathionine beta-synthase (CBS) deficiency, can lead to serious health issues.
  • Early intervention is crucial for preventing severe complications associated with this metabolic disorder.

Purpose of the Study:

  • To determine the prevalence of specific cystathionine beta-synthase mutations in newborns.
  • To assess the frequency of homocystinuria in the studied population.

Main Methods:

  • Analysis of 1133 newborn blood samples.
  • Detection of 6 specific mutations associated with cystathionine beta-synthase deficiency.

Main Results:

  • The study identified a higher prevalence of homocystinuria than previously reported.
  • Specific mutation frequencies were established in the newborn cohort.

Conclusions:

  • Homocystinuria may be more common in the population than current estimates suggest.
  • Newborn screening for homocystinuria via mutation detection warrants further consideration for early diagnosis and management.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...